Furthermore, it is conceivable that levels of specific DNA repair proteins may be titrated to achieve positive therapeutic outcomes in the context of specific hereditary cancer syndromes, exemplified by FAP. Here, XRCC6P5 is linked to Inherited cancer-predisposing syndrome.